BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors - Yahoo! Finance -BoardProspects

BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors

Yahoo! Finance Jul 5 2022 BoardMoves

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the appointment of Michael P. Miller to its Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- D.C. United’s Danita Johnson Becomes First Woman To Join Buzzer’s Board Of Directors also categorized in BoardMoves
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- Transocean chairman Talbert to retire also published in Yahoo! Finance

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned